BRASILIA (Reuters) - Brazil's Senate on Thursday approved a bill to suspend patent protection for COVID-19 vaccines, tests and medications during the pandemic, sending the proposal to the lower house of Congress for consideration and possible amendments.
It remains unclear if lower house lawmakers will pass the bill, with implications for pharmaceutical firms such as AstraZeneca and China's Sinovac Biotech, which have arranged local production of their COVID-19 vaccines.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!